These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9702786)

  • 1. Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families.
    Etcheberrigaray R; Hirashima N; Nee L; Prince J; Govoni S; Racchi M; Tanzi RE; Alkon DL
    Neurobiol Dis; 1998 Jul; 5(1):37-45. PubMed ID: 9702786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium responses in human fibroblasts: a diagnostic molecular profile for Alzheimer's disease.
    Hirashima N; Etcheberrigaray R; Bergamaschi S; Racchi M; Battaini F; Binetti G; Govoni S; Alkon DL
    Neurobiol Aging; 1996; 17(4):549-55. PubMed ID: 8832629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of TEA-induced calcium responses in fibroblasts from Alzheimer's disease patients by a PKC activator.
    Bhagavan S; Ibarreta D; Ma D; Kozikowski AP; Etcheberrigaray R
    Neurobiol Dis; 1998 Sep; 5(3):177-87. PubMed ID: 9848089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin.
    Khan TK; Alkon DL
    Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13203-7. PubMed ID: 16920798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PHA-induced calcium signal in lymphocytes is altered after blockade of K(+)-channels in Alzheimer's disease.
    Bondy B; Hofmann M; Müller-Spahn F; Witzko M; Hock C
    J Psychiatr Res; 1996; 30(3):217-27. PubMed ID: 8884660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased adhesiveness of Alzheimer's disease fibroblasts: is amyloid beta-protein precursor involved?
    Uéda K; Cole G; Sundsmo M; Katzman R; Saitoh T
    Ann Neurol; 1989 Mar; 25(3):246-51. PubMed ID: 2729915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of calcium in Alzheimer's disease.
    Brzyska M; Elbaum D
    Acta Neurobiol Exp (Wars); 2003; 63(3):171-83. PubMed ID: 14518509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and phosphorylation of delta-CaM kinase II in cultured Alzheimer fibroblasts.
    Cavazzin C; Bonvicini C; Nocera A; Racchi M; Kasahara J; Tardito D; Gennarelli M; Govoni S; Racagni G; Popoli M
    Neurobiol Aging; 2004 Oct; 25(9):1187-96. PubMed ID: 15312964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronically increased oxidative stress in fibroblasts from Alzheimer's disease patients causes early senescence and renders resistance to apoptosis by oxidative stress.
    Naderi J; Lopez C; Pandey S
    Mech Ageing Dev; 2006 Jan; 127(1):25-35. PubMed ID: 16188294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients.
    Cazzaniga E; Bulbarelli A; Lonati E; Re F; Galimberti G; Gatti E; Pitto M; Ferrarese C; Masserini M
    Neurosci Lett; 2008 May; 436(3):317-20. PubMed ID: 18406523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients.
    McLarnon JG; Choi HB; Lue LF; Walker DG; Kim SU
    J Neurosci Res; 2005 Aug; 81(3):426-35. PubMed ID: 15948178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease.
    Smith IF; Hitt B; Green KN; Oddo S; LaFerla FM
    J Neurochem; 2005 Sep; 94(6):1711-8. PubMed ID: 16156741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormality of the alpha-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease.
    Sheu KF; Cooper AJ; Koike K; Koike M; Lindsay JG; Blass JP
    Ann Neurol; 1994 Mar; 35(3):312-8. PubMed ID: 8122883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Change of fibroblast calcium levels caused by beta-amyloid peptide in Alzheimer disease].
    Palotás A; Kálmán J; Laskay G; Juhász A; Janka Z; Penke B
    Ideggyogy Sz; 2002 May; 55(5-6):164-7. PubMed ID: 12122875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels.
    Zatti G; Burgo A; Giacomello M; Barbiero L; Ghidoni R; Sinigaglia G; Florean C; Bagnoli S; Binetti G; Sorbi S; Pizzo P; Fasolato C
    Cell Calcium; 2006 Jun; 39(6):539-50. PubMed ID: 16620965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
    Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
    Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimer's disease.
    Peterson C; Gibson GE; Blass JP
    N Engl J Med; 1985 Apr; 312(16):1063-5. PubMed ID: 3982463
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
    Ladner CJ; Lee JM
    Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice.
    Eckert A; Schindowski K; Leutner S; Luckhaus C; Touchet N; Czech C; Müller WE
    Neurobiol Dis; 2001 Apr; 8(2):331-42. PubMed ID: 11300728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of AMPA responses by mutated presenilin 1.
    Moerman AM; Barger SW
    J Neurosci Res; 1999 Sep; 57(6):962-7. PubMed ID: 10467268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.